<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Health Clinical research Pharmacology Pharmaceutical industry Drug safety Prescription Drug User Fee Act Center for Drug Evaluation and Research Investigational New Drug Clinical trial Food and Drug Administration Pharmaceutical sciences Research |
Add to Reading List |
Microsoft Word[removed]doc | Morphochem’s Investigational New Drug (IND) application accepted by FDA – Novel antibacterial for IV treatment of CDI ready to move to Phase 2 Munich (Germany), June 22, 2016 — Morphochem, a clinical-stage pharmaceDocID: 1uvYN - View Document |
| Guidance for Industry Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic,DocID: 1sDEk - View Document |
| Emergency Use: means the use of a test article on a human subject in a life-threatening situation inDocID: 1riMu - View Document |
| Microsoft Word - 7494fnl.docDocID: 1qYy2 - View Document |
| Microsoft WorddocDocID: 1qVAJ - View Document |